Neuroimmune guidance cue semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 5, 2013, Pages 886-893

  Wanschel, Amarylis ^a   Seibert, Tara ^b   Hewing, Bernd ^a   Ramkhelawon, Bhama ^c   Ray, Tathagat D ^a   Van Gils, Janine M ^a   Rayner, Katey J ^b   Feig, Jonathan E ^a   O'Brien, Edward R ^b   Fisher, Edward A ^a   Moore, Kathryn J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

atherosclerosis; macrophage; migration; regression; Semaphorin 3E

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PLEXIN; PLEXIN D1; SEMAPHORIN; SEMAPHORIN 3E; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CDC42 GTP-BINDING PROTEIN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; GLYCOPROTEINS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PLAQUE, ATHEROSCLEROTIC;

EID: 84876292187     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300941     Document Type: Article

References (45)

1. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol. 2011;31:1506-1516.
2. Ye D, Zhao Y, Hildebrand RB, Singaraja RR, Hayden MR, Van Berkel TJ, Van Eck M. The dynamics of macrophage infltration into the arterial wall during atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. Am J Pathol. 2011;178:413-422.
3. Bellingan GJ, Caldwell H, Howie SE, Dransfeld I, Haslett C. In vivo fate of the infammatory macrophage during the resolution of infammation: infammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol. 1996;157:2577-2585.
4. Llodrá J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA. 2004;101:11779-11784.
5. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, Tacke F, Randolph GJ, Fisher EA. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-defcient mice. Proc Natl Acad Sci USA. 2006;103:3781-3786.
6. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA. HDL promotes rapid atherosclerosis regression in mice and alters infammatory properties of plaque mono-cyte-derived cells. Proc Natl Acad Sci USA. 2011;108:7166-7171.
7. Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest. 2011;121:2921-2931.
8. Feig JE, Pineda-Torra I, Sanson M, et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest. 2010;120:4415-4424.
9. Melani M, Weinstein BM. Common factors regulating patterning of the nervous and vascular systems. Annu Rev Cell Dev Biol. 2010;26:639-665.
10. Perälä N, Sariola H, Immonen T. More than nervous: the emerging roles of plexins. Differentiation. 2012;83:77-91.
11. Sakurai A, Gavard J, Annas-Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H, Zhang F, Randazzo PA, Li X, Weigert R, Gutkind JS. Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol. 2010;30:3086-3098.
12. Cirulli V, Yebra M. Netrins: beyond the brain. Nat Rev Mol Cell Biol. 2007;8:296-306.
13. van Gils JM, Derby MC, Fernandes LR, et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol. 2012;13:136-143.
14. Chereshnev I, Trogan E, Omerhodzic S, Itskovich V, Aguinaldo JG, Fayad ZA, Fisher EA, Reis ED. Mouse model of heterotopic aortic arch transplantation. J Surg Res. 2003;111:171-176.
15. Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, Garabedian MJ, Fisher EA, Puig O. Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS ONE. 2012;7:e39790.
16. Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-defcient mice. Proc Natl Acad Sci USA. 2002;99:2234-2239.
17. Nakamura F, Kalb RG, Strittmatter SM. Molecular basis of semaphorin-mediated axon guidance. J Neurobiol. 2000;44:219-229.
18. Raper JA. Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol. 2000;10:88-94.
19. Steinbach K, Volkmer H, Schlosshauer B. Semaphorin 3E/collapsin-5 inhibits growing retinal axons. Exp Cell Res. 2002;279:52-61.
20. Püschel AW. Semaphorins: repulsive guidance molecules show their attractive side. Nat Neurosci. 1999;2:777-778.
21. Trogan E, Fayad ZA, Itskovich VV, Aguinaldo JG, Mani V, Fallon JT, Chereshnev I, Fisher EA. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb Vasc Biol. 2004;24:1714-1719.
22. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, Young SG, Fisher EA. Reversal of hyperlipidemia with a genetic switch favorably affects the content and infammatory state of macrophages in atherosclerotic plaques. Circulation. 2011;123:989-998.
23. Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol effux and immune responses. Arterioscler Thromb Vasc Biol. 2010;30:139-143.
24. Choi YI, Duke-Cohan JS, Ahmed WB, Handley MA, Mann F, Epstein JA, Clayton LK, Reinherz EL. PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla. Immunity. 2008;29:888-898.
25. Jimenez F, Quinones MP, Martinez HG, Estrada CA, Clark K, Garavito E, Ibarra J, Melby PC, Ahuja SS. CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol. 2010;184:5571-5581.
26. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS. Cc chemokine receptor (ccr)2 is required for Langerhans cell migration and localization of t helper cell type 1 (th1)-inducing dendritic cells. Absence of ccr2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by th2 cyto-kines, b cell outgrowth, and sustained neutrophilic infammation. J Exp Med. 2000;192:205-218.
27. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341-355.
28. Williams KJ, Feig JE, Fisher EA. Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med. 2008;5:91-102.
29. Mangasser-Stephan K, Dooley S, Welter C, Mutschler W, Hanselmann RG. Identifcation of human semaphorin E gene expression in rheumatoid synovial cells by mRNA differential display. Biochem Biophys Res Commun. 1997;234:153-156.
30. Miller LE, Weidler C, Falk W, Angele P, Schaumburger J, Schölmerich J, Straub RH. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fbers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2004;50:1156-1163.
31. Yukawa K, Tanaka T, Kishino M, Yoshida K, Takeuchi N, Ito T, Takamatsu H, Kikutani H, Kumanogoh A. Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-defcient mice. Int J Mol Med. 2010;26:39-44.
32. Zhu L, Stalker TJ, Fong KP, Jiang H, Tran A, Crichton I, Lee EK, Neeves KB, Maloney SF, Kikutani H, Kumanogoh A, Pure E, Diamond SL, Brass LF. Disruption of SEMA4D ameliorates platelet hypersensitivity in dys-lipidemia and confers protection against the development of atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1039-1045.
33. Hughes A, Kleine-Albers J, Helfrich MH, Ralston SH, Rogers MJ. A class III semaphorin (Sema3E) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro. Calcif Tissue Int. 2012;90:151-162.
34. Fukushima Y, Okada M, Kataoka H, Hirashima M, Yoshida Y, Mann F, Gomi F, Nishida K, Nishikawa S, Uemura A. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J Clin Invest. 2011;121:1974-1985.
35. Ding JB, Oh WJ, Sabatini BL, Gu C. Semaphorin 3E-Plexin-D1 signaling controls pathway-specifc synapse formation in the striatum. Nat Neurosci. 2012;15:215-223.
36. Gu C, Yoshida Y, Livet J, Reimert DV, Mann F, Merte J, Henderson CE, Jessell TM, Kolodkin AL, Ginty DD. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science. 2005;307:265-268.
37. Klagsbrun M, Shimizu A. Semaphorin 3E, an exception to the rule. J Clin Invest. 2010;120:2658-2660.
38. Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K, Zhang Z, Nozaki S, Matsuzawa Y. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinfammatory genes are defective in monocyte-derived macrophages from CD36-defcient patients. Arterioscler Thromb Vasc Biol. 2000;20:1953-1960.
39. Gay CM, Zygmunt T, Torres-Vázquez J. Diverse functions for the semapho-rin receptor PlexinD1 in development and disease. Dev Biol. 2011;349:1-19.
40. Wang Y, He H, Srivastava N, Vikarunnessa S, Chen YB, Jiang J, Cowan CW, Zhang X. Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization. Sci Signal. 2012;5:ra6.
41. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, Clement M, Dussiot M, Levillain O, Graff-Dubois S, Nicoletti A, Caligiuri G. Macrophage plasticity in experimental atherosclerosis. PLoS ONE. 2010;5:e8852.
42. Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebendahl K, Thiery J. Identifcation of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler Thromb Vasc Biol. 2006;26:365-371.
43. Parathath S, Grauer L, Huang LS, Sanson M, Distel E, Goldberg IJ, Fisher EA. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes. 2011;60:1759-1769.
44. Gerszten RE, Tager AM. The monocyte in atherosclerosis-should I stay or should I go now? N Engl J Med. 2012;366:1734-1736.
45. Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, Moore KJ, Kinane TB. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA. 2005;102:14729-14734.